Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 2008 Aug;53(8):2246-50.
doi: 10.1007/s10620-007-0109-6. Epub 2007 Nov 30.

Liver histology changes in nonalcoholic steatohepatitis after one year of treatment with probucol

Shahin Merat  1 , Mohsen Aduli, Rozana Kazemi, Masoud Sotoudeh, Nahid Sedighi, Masoud Sohrabi, Reza Malekzadeh
Affiliations
Clinical Trial

Liver histology changes in nonalcoholic steatohepatitis after one year of treatment with probucol

Shahin Merat et al. Dig Dis Sci. 2008 Aug.

Abstract

Background: Probucol, a lipid-lowering agent with antioxidant effects, is effective in normalizing liver enzymes in patients with nonalcoholic steatohepatitis (NASH). We studied changes in the liver histology of patients with NASH after use of probucol for one year.

Methods: Ten patients with biopsy-proven NASH were included. Subjects were given 500 mg probucol daily. Liver biopsies were performed before treatment and after one year.

Results: Eight patients completed treatment. The mean alanine aminotransferase (ALT) and aspartate aminotransferase (AST) levels decreased from 94 and 55 to 41 and 26, respectively (P = 0.004 and 0.001 respectively). The scores for hepatic steatosis and necroinflammation decreased from 7.4 to 5.6 (P = 0.03). The fibrosis score changed from 1.1 to 1.3 (P = 0.79). No adverse drug effects were observed.

Conclusion: Probucol is effective in normalizing aminotransferase levels in patients with NASH. It also significantly reduces the histology grade of steatohepatitis after one year of treatment.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. J Hepatol. 2005;42 Suppl(1):S2-12 - PubMed
    1. Clin Gastroenterol Hepatol. 2004 Dec;2(12):1107-15 - PubMed
    1. Cochrane Database Syst Rev. 2007 Jan 24;(1):CD005165 - PubMed
    1. J Hepatol. 2003 Apr;38(4):414-8 - PubMed
    1. Endocr Pract. 2005 Sep-Oct;11(5):319-24 - PubMed

Publication types

LinkOut - more resources